Abstract

The mechanism of sepsis-induced cardiac dysfunction is believed to be different from that of myocardial ischemia. In sepsis, chemical mediators, such as endotoxins, cytokines, and nitric oxide, cause metabolic abnormalities, mitochondrial dysfunction, and downregulation of β-adrenergic receptors. These factors inhibit the production of ATP, essential for myocardial energy metabolism, resulting in cardiac dysfunction. This review focuses on the metabolic changes in sepsis, particularly in the heart. In addition to managing inflammation, interventions focusing on metabolism may be a new therapeutic strategy for cardiac dysfunction due to sepsis.

Highlights

  • This review focuses on the current knowledge of metabolic alteration in sepsis, especially the dysregulation of cardiac metabolism

  • Our findings demonstrated that (1) β3AR is increased in septic hearts; (2) β3AR blockade preserves cardiac adenosine triphosphate (ATP) through the improvement of FAO; (3) β3AR blockade prevents lipid accumulation in the myocardium; and (4) β3AR regulates inducible NO synthase (iNOS)

  • This review focuses on cardiac metabolism in sepsis

Read more

Summary

Introduction

Cardiovascular abnormalities in sepsis have been known since the 1950s [8], Parker et al reported that intrinsic myocardial dysfunction, with an increased volume and a decreased ejection fraction, in patients with sepsis is reversible [9] These functional changes in the left ventricle were observed 7–10 days from the onset in survivors, whereas they were less profound in non-survivors [9,10]. Some clinical researchers suggested that cardiac dysfunction in sepsis is strongly associated with mortality [16,17,18,19] These different conclusions might result from the complexity of the disease, patient characteristics, methods of diagnosis, and disease access.

Fatty Acid Metabolism
Glucose Oxidation
Ketone Metabolism
Amino Acid Metabolism
Mitochondrial Metabolism
Lipid Metabolism in Sepsis
Glucose Metabolism in Sepsis
Amino Acid Metabolism in Sepsis
Mitochondrial Metabolism in Sepsis
Therapeutic Strategies to Metabolism in SICM
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.